Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

NCT02131220 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

362

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction
Percutaneous Coronary Intervention
Thrombolytic Therapy

Interventions

DRUG: Prourokinase
DRUG: Tirofiban
DRUG: normal saline

Sponsor

Fudan University